Neurocrine Biosciences Inc (NBIX)

04:47 AM

Neurocrine to buy Soleno Therapeutics for $53/share in cash - MSN

04:47 AM

Apr 28, 2026

Soleno Therapeutics rallies on report of $2.5B Neurocrine buyout talks - MSN

Apr 28, 2026

Apr 28, 2026

Neurocrine-Soleno deal garners Wall Street praise — analyst applauds business development acumen - MSN

Apr 28, 2026

Apr 28, 2026

Neurocrine, Soleno HSR waiting period expired April 27 - MLex

Apr 28, 2026

Apr 28, 2026

Neurocrine Biosciences-Soleno Therapeutics HSR waiting period expired April 27 - MLex

Apr 28, 2026

Apr 28, 2026

Neurocrine (NASDAQ: SLNO) to acquire Soleno for $53.00 per share after HSR clearance - Stock Titan

Apr 28, 2026

Apr 27, 2026

Neurocrine to buy Soleno Therapeutics for $2.9 billion - MSN

Apr 27, 2026

Apr 27, 2026

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Unlocking a 45% Upside Potential Amid Strong Buy Ratings - DirectorsTalk Interviews

Apr 27, 2026

Apr 27, 2026

Soleno Therapeutics stock rallies 56.4% in a week: Here's why - msn.com

Apr 27, 2026

Apr 27, 2026

Wall Street analysts think Neurocrine (NBIX) could surge 38.79%: Read this before placing a bet - MSN

Apr 27, 2026

Apr 26, 2026

A Look At Neurocrine Biosciences (NBIX) Valuation After CRENESSITY Phase 3 CAHtalyst Adult Results - simplywall.st

Apr 26, 2026

Apr 26, 2026

Neurocrine to buy Soleno for treatment for rare disease that causes relentless hunger - MSN

Apr 26, 2026

Apr 26, 2026

Munich Reinsurance Co Stock Corp in Munich Buys 10,168 Shares of Neurocrine Biosciences, Inc. $NBIX - MarketBeat

Apr 26, 2026

Apr 25, 2026

Neurocrine nears $2.5B-plus deal to buy Soleno TherapeuticsFT - MSN

Apr 25, 2026

Apr 25, 2026

CRENESSITY Phase 3 Data on Lower Steroid Doses Could Be A Game Changer For Neurocrine Biosciences (NBIX) - simplywall.st

Apr 25, 2026

Apr 25, 2026

Neurocrine Biosciences (NASDAQ:NBIX) Raised to Strong-Buy at Wall Street Zen - MarketBeat

Apr 25, 2026

Apr 24, 2026

NBIX News | NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) - ChartMill

Apr 24, 2026

Apr 23, 2026

Morgan Stanley Maintains Neurocrine Biosciences (NBIX) Overweight Recommendation - MSN

Apr 23, 2026

Apr 23, 2026

Ruffer LLP Invests $2.48 Million in Neurocrine Biosciences, Inc. $NBIX - MarketBeat

Apr 23, 2026

Apr 23, 2026

Deutetrabenazine Market to Witness Massive Growth by 2033 |Teva - openPR.com

Apr 23, 2026

Apr 23, 2026

Neurocrine reports sustained glucocorticoid reductions in CAH study By Investing.com - Investing.com India

Apr 23, 2026

Apr 23, 2026

Zurcher Kantonalbank Zurich Cantonalbank Boosts Stock Position in Neurocrine Biosciences, Inc. $NBIX - MarketBeat

Apr 23, 2026

Apr 22, 2026

Neurocrine reports sustained glucocorticoid reductions in CAH study - Investing.com

Apr 22, 2026

Apr 22, 2026

Neurocrine reports sustained dose reductions with CRENESSITY in CAH patients - StreetInsider

Apr 22, 2026

Apr 22, 2026

Rare adrenal disorder drug helped 7 in 10 adults cut steroid doses - Stock Titan

Apr 22, 2026

Apr 22, 2026

NBIX Maintained by Leerink Partners -- Price Target Raised to $1 - GuruFocus

Apr 22, 2026

Apr 22, 2026

How Neurocrine Biosciences Inc. (NBIX) Affects Rotational Strategy Timing - Stock Traders Daily

Apr 22, 2026

Apr 22, 2026

Neurocrine Biosciences (NASDAQ:NBIX) Price Target Raised to $170.00 - MarketBeat

Apr 22, 2026

Apr 22, 2026

Belpointe Asset Management LLC Acquires Shares of 9,485 Neurocrine Biosciences, Inc. $NBIX - MarketBeat

Apr 22, 2026

Apr 21, 2026

Why this Bay Area company took a buyout offer that was nearly $2 billion less than an earlier bid - The Business Journals

Apr 21, 2026

Apr 21, 2026

3 Reasons Growth Investors Will Love Neurocrine (NBIX) - Yahoo Finance

Apr 21, 2026

Apr 21, 2026

Morgan Stanley Maintains Neurocrine Biosciences(NBIX.US) With Hold Rating, Maintains Target Price $185 - Moomoo

Apr 21, 2026

Apr 21, 2026

Wall Street Analysts Think Neurocrine (NBIX) Could Surge 38.79%: Read This Before Placing a Bet - Yahoo Finance

Apr 21, 2026

Apr 21, 2026

NBIX Stock Chart | NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) - ChartMill

Apr 21, 2026

Apr 21, 2026

Lobbying Update: $940,000 of NEUROCRINE BIOSCIENCES INC lobbying was just disclosed - Quiver Quantitative

Apr 21, 2026

Apr 20, 2026

Neurocrine is making a $2.9 billion bet on a new kind of drug - MSN

Apr 20, 2026

Apr 20, 2026

Neurocrine Biosciences (NASDAQ: SLNO) offers $53.00 per share cash to Soleno - Stock Titan

Apr 20, 2026

Apr 20, 2026

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Unveiling a 39.92% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews

Apr 20, 2026

Apr 20, 2026

KBC Group NV Has $4.60 Million Stock Holdings in Neurocrine Biosciences, Inc. $NBIX - MarketBeat

Apr 20, 2026

Apr 20, 2026

Fortis Capital Advisors LLC Invests $1.35 Million in Neurocrine Biosciences, Inc. $NBIX - MarketBeat

Apr 20, 2026

Apr 19, 2026

A Look At Neurocrine Biosciences (NBIX) Valuation After New INGREZZA Persistence Data And Options Activity - simplywall.st

Apr 19, 2026

Apr 19, 2026

NBIX SEC FilingsNeurocrine Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 19, 2026

Apr 19, 2026

Cwm LLC Purchases 11,306 Shares of Neurocrine Biosciences, Inc. $NBIX - MarketBeat

Apr 19, 2026

Apr 17, 2026

A Look at Neurocrine Biosciences Inc (NBIX) After 3.8% Gain -- G - GuruFocus

Apr 17, 2026

Apr 17, 2026

Neurocrine's Acquisition Impacts Soleno Therapeutics (SLNO) Rati - GuruFocus

Apr 17, 2026

Apr 17, 2026

How New Real-World INGREZZA Data Versus AUSTEDO XR Will Impact Neurocrine Biosciences (NBIX) Investors - simplywall.st

Apr 17, 2026